SCHEDULE: ING Groep Discloses 3.99% Stake in NEOGEN CORP
Beneficial Ownership Report
ING Groep N.V. and its subsidiary, ING Capital Markets LLC, have filed an amended Schedule 13G disclosing a beneficial ownership of 3.99% in NEOGEN CORP common stock.
Summary
- ING Groep N.V. and its wholly-owned subsidiary, ING Capital Markets LLC, are the reporting persons.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating a change from a previous filing.
- The beneficial ownership totals 8,673,700 shares of NEOGEN CORP Common Stock.
- This represents 3.99% of NEOGEN CORP's outstanding common stock as of August 31, 2025.
- The calculation is based on 217,298,626 shares of common stock outstanding, as reported in NEOGEN CORP's Quarterly Report on Form 10-Q filed on October 9, 2025.
- Both reporting persons share voting and dispositive power over all 8,673,700 shares.
- The securities were not acquired for the purpose of changing or influencing the control of NEOGEN CORP.
Sentiment
Score: 5
Explanation: The filing is a neutral, factual disclosure of beneficial ownership and does not contain information that would inherently convey positive or negative sentiment regarding the company's performance or prospects.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
NA
Industry Context
This filing is a routine disclosure of institutional ownership and does not provide specific insights into broader industry trends or competitive landscape for NEOGEN CORP.
Related Party Transactions
- ING Capital Markets LLC, a reporting person, is a wholly-owned subsidiary of ING Groep N.V., the other reporting person, indicating a related party relationship in their beneficial ownership of NEOGEN CORP shares.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by ING Groep N.V. and its subsidiary provides transparency regarding the ownership structure of NEOGEN CORP.
Key Dates
| Date | Description |
|---|---|
| 2025-08-31 | Date as of which NEOGEN CORP's common stock outstanding (217,298,626 shares) was reported in its Form 10-Q. |
| 2025-10-09 | Date NEOGEN CORP filed its Quarterly Report on Form 10-Q for the period ended August 31, 2025. |
| 2025-11-28 | Date of the event which required the filing of this Schedule 13G Amendment No. 1. |
| 2025-12-04 | Date the Schedule 13G Amendment No. 1 was signed by the reporting persons. |
Keywords
NEOGEN CORP, ING Groep NV, ING Capital Markets LLC, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.